{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:PDGF",
      "entity_text" : "PDGF",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03204",
      "entity_text" : "miR-106b-5p",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "miR-106b-5p levels were decreased 0.75-fold, 0.4-fold and 0.39-fold when treated with 10, 20 and 40 ng/ml PDGF, respectively, compared with the control group (XREF_FIG).",
  "reading_complete" : "2020-08-02T16:06:57Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T16:05:34Z",
  "trigger" : "decreased",
  "evidence" : [ "miR-106b-5p levels were decreased 0.75-fold, 0.4-fold and 0.39-fold when treated with 10, 20 and 40 ng/ml PDGF" ],
  "pmc_id" : "7138273",
  "score" : 0
}